戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 r Arg90Cit and Glu52Ala mutants, and the 1F7 catalytic antibody.
2 Cope rearrangement compared to the germ line catalytic antibody.
3 tes in conjunction with a unique broad-scope catalytic antibody.
4 state stabilization in the evolution of this catalytic antibody.
5 r effect on reactions promoted by engineered catalytic antibodies.
6 erate the germline and affinity-matured AZ28 catalytic antibodies.
7 splay to generate a panel of closely related catalytic antibodies.
8 low the procurement of a wide range of novel catalytic antibodies.
9                                          The catalytic antibody 13G5 catalyzes a disfavored exo Diels
10                                              Catalytic antibody 15A10 hydrolyzes the benzoyl ester of
11  antigen binding loops from a murine-derived catalytic antibody, 17E8, onto a human antibody framewor
12  steroids to antibody DB3 and of a hapten to catalytic antibody 1E9 are computed and compared to expe
13 ight into the evolution of the redox active, catalytic antibody 28B4, the germline genes used by the
14 graphic structure of the Fab fragment of the catalytic antibody, 29G11, complexed with an (S)-norleuc
15 ivities (% ee) derived from an enamine-based catalytic antibody 33F12 and a chiral organocatalyst.
16    Furthermore, this is the first example of catalytic antibody 38C2 displaying regioselectivity on a
17                                          The catalytic antibody 38C2 only reacted with surface-expose
18                                 In addition, catalytic antibody 38C2 was able to selectively differen
19 tivation using the prohormone insulin(D) and catalytic antibody 38C2 with potential therapeutic appli
20        The crystal structure of the esterase catalytic antibody 48G7 has been determined in the prese
21 posure to the bacterium and reduction of the catalytic antibody activity following infection.
22  to the substrate (the compound on which the catalytic antibody acts) lead to dramatic differences in
23     Here we demonstrate a novel CocH form, a catalytic antibody analog, which is a fragment crystalli
24 eve this goal: namely, computational design, catalytic antibodies and mRNA display.
25 fficiency of natural enzymes evolve, but the catalytic antibodies are much more accepting of a wide r
26                            Catalytic and non-catalytic antibodies are studied in this context of acti
27                Sequence analysis of the four catalytic antibodies, as well as four inactive antibodie
28 tic receptor fulfils a role reminiscent of a catalytic antibody by stabilizing the planar transition
29                                              Catalytic antibodies (CAbs) occur naturally in healthy i
30                                              Catalytic antibodies capable of oxidatively degrading th
31                     Peptide bond-hydrolyzing catalytic antibodies (catabodies) could degrade toxic pr
32 assical immunization methods do not generate catalytic antibodies (catabodies), but recent findings s
33                          In this approach, a catalytic antibody catalyzes the covalent conjugation of
34 turnover of a photochemical reaction using a catalytic antibody could be observed.
35 inogen activator inhibitor, addition of anti-catalytic antibodies directed against urokinase plasmino
36 of four related Fab fragments of a family of catalytic antibodies displaying differential levels of e
37            An array of substances, including catalytic antibodies, DNA, RNA, antigens, live bacterial
38  by antibodies 13G5 and 4D5 as well as other catalytic antibodies elicited in the same immunizations
39                                  Activity of catalytic antibodies for hydrolysis of enol ethers is de
40 g the first example of a naturally occurring catalytic antibody for polysaccharides.
41 s indicate the power of initial selection of catalytic antibodies from a biased antibody library in b
42                             The existence of catalytic antibodies has been known for decades.
43                                 The forte of catalytic antibodies has resided in the control of the g
44                                              Catalytic antibodies have been shown to have chemoselect
45                                 However, few catalytic antibodies have efficiencies that approach tho
46                                              Catalytic antibodies have emerged as being without peer
47                                              Catalytic antibodies have shown great promise for cataly
48                     Many naturally occurring catalytic antibodies have since been isolated from human
49       This study demonstrates the utility of catalytic antibodies in examining the relationship betwe
50                                              Catalytic antibodies induced by GNT-KLH were also shown
51                    Although the discovery of catalytic antibodies initially aroused great interest be
52                   One of the fascinations of catalytic antibodies is the possibility of harnessing th
53 t catalysts for related reactions, including catalytic antibodies (kcat/kuncat=10(6) to 10(8)) and an
54 pplicable in repetitive format for screening catalytic antibody libraries.
55 To provide a new approach, the high-activity catalytic antibody mAb 15A10 was elicited using a transi
56 aine hydrolysis catalyzed by an anti-cocaine catalytic antibody, mAb15A10, were studied by using a no
57  report a chemotherapeutic strategy based on catalytic antibody-mediated prodrug activation.
58 g the chemistry of the well studied aldolase catalytic antibodies of which mAb 38C2 is a member.
59                                       Whilst catalytic antibodies, on average, have marginally higher
60            Re-engineered natural enzymes and catalytic antibodies, possessing tailored binding pocket
61 cellular fibrinogen-binding protein (Efb) by catalytic antibodies produced with no exposure to the ba
62 erent from that induced by the antibody; the catalytic antibody produces a distortion which is simila
63  and structural data are consistent with the catalytic antibody providing oxyanion stabilization as i
64  cloning and kinetic analysis of a family of catalytic antibodies raised against a common transition
65              In this regard, the presence of catalytic antibodies recognizing host antigens has been
66 is one of the most promising achievements of catalytic antibody research.
67 n as one of the few systems where the mature catalytic antibody shows a negative correlation between
68 une system and reveals that the evolution of catalytic antibodies significantly predates their ration
69  putative site was found in 14 of 63 (22.2%) catalytic antibody structures and 119 of 1602 (7.4%) ant
70  these structures are the highest resolution catalytic antibody structures to date and provide insigh
71  within the hydrophobic environments of this catalytic antibody than speculated for natural aldolase
72                This process yielded aldolase catalytic antibodies that approximated the rate accelera
73 n criteria of the immune system are changed, catalytic antibodies that have the efficiency of natural
74                                          IgG catalytic antibodies that specifically hydrolyzed Efb vi
75           A powerful application resulted in catalytic antibodies that use an enamine mechanism akin
76 body 38C2 is the prototype of a new class of catalytic antibodies that were generated by reactive imm
77  the key lessons learned from the science of catalytic antibodies--that binding energy can be convert
78                                        Among catalytic antibodies, the well-characterized antibody 43
79 arginally higher active site burial than non-catalytic antibodies, these values are generally smaller
80 defense function for constitutively produced catalytic antibodies to a putative superantigenic site o
81             Furthermore, naturally occurring catalytic antibodies to microbial determinants have been
82 s can be readily used to optimize binding of catalytic antibodies to transition-state analogs, and wh
83             This is an inaugural report of a catalytic antibody utilizing dendrimers as substrates an
84                                          The catalytic antibodies were prepared by reactive immunizat
85 ese prodrugs are selectively unmasked by the catalytic antibody when it is applied at therapeutically
86 nues for the improvement of first generation catalytic antibodies with chorismate mutase activity.
87 yield a functional single-chain version of a catalytic antibody with chorismate mutase activity.
88 rationally designed cocaine antagonist and a catalytic antibody with potential for medicinal use.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。